Paula Deen Sells Her Soul
January 31, 2012 by Bob Livingston
Paula Deen, the Southern chef known for creating fat- and sugar-laden dishes, has sold her soul to the devil that is Big Pharma.
Deen now admits that she was diagnosed with type 2 diabetes three years ago. But rather than use her bully pulpit to preach a lifestyle of making healthy eating choices, Deen is now promoting the diabetes drug liraglutide (Victoza) manufactured by Novo Nordisk.
The Food and Drug Administration approved Victoza in January 2010, but it did so amid strong evidence of a link to thyroid cancer. The FDA ordered Novo Nordisk to include a “black box” warning on the drug’s label. A black box warning is the agency’s strongest warning and is used only when grave side effects are at issue. The warning states that the drug causes thyroid C-cell tumors in rodents. If the FDA — which cares only about Big Pharma profits and not a whit for the health of Americans — requires a black box warning, the cancer risk must be enormous.
Deen would do more for the health of her fans if she would talk to them about eating healthful, whole and raw foods and avoiding trans fats and sugars, especially high fructose corn syrup. Instead, she sold her soul. Those who follow her advice to continue eating “pleasure” foods and just turn to Big Pharma for a cure are embarking on a journey in which the cure can be worse than the disease.